277 related articles for article (PubMed ID: 32418649)
1. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
[TBL] [Abstract][Full Text] [Related]
2. Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.
Chen H; Zhou L; Yang Y; Yang L; Chen L
Med Sci Monit; 2018 Jun; 24():4183-4191. PubMed ID: 29915168
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.
Li C; Tan L; Liu X; Wang X; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Bi N; Deng L; Wang W; Zhang T; Ni W; Chang X; Han W; Gao L; Wang S; Xiao Z
Thorac Cancer; 2021 Jun; 12(12):1831-1840. PubMed ID: 33949784
[TBL] [Abstract][Full Text] [Related]
4. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
Chen M; Liu X; Han C; Wang X; Zhao Y; Pang Q; Sun X; Li G; Zhang K; Li L; Qiao X; Lin Y; Chen J; Xiao Z
BMC Cancer; 2020 Jan; 20(1):36. PubMed ID: 31941487
[TBL] [Abstract][Full Text] [Related]
5. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Chen M; Shen M; Lin Y; Liu P; Liu X; Li X; Li A; Yang R; Ni W; Zhou X; Zhang L; Xu B; Lin J; Chen J; Tian Y
Radiat Oncol; 2018 Aug; 13(1):150. PubMed ID: 30111361
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.
Huang C; Zhu Y; Li Q; Zhang W; Liu H; Zhang W; Hu Y; Yuan Y; Liu M
Cancer Med; 2019 Jan; 8(1):28-39. PubMed ID: 30600600
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
9. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
Chen F; Luo H; Xing L; Liang N; Xie J; Zhang J
Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
[TBL] [Abstract][Full Text] [Related]
10. Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
Wang J; Xiao L; Wang S; Pang Q; Wang J
Front Oncol; 2021; 11():665231. PubMed ID: 34589418
[TBL] [Abstract][Full Text] [Related]
11. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
[TBL] [Abstract][Full Text] [Related]
12. Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
Liu Y; Zheng Z; Li M; Zhang Y; Zhao F; Gong H; Lin H; Huang W; Chen X; Xu Z; Li X; Liu W; Cui Y; Zheng A; Li B
Int J Cancer; 2022 Aug; 151(4):607-615. PubMed ID: 35419831
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
Zhao Z; Zhang Y; Wang X; Geng X; Zhu L; Li M
Cancer Med; 2020 Aug; 9(16):5881-5888. PubMed ID: 32627960
[TBL] [Abstract][Full Text] [Related]
15. Survival comparision of three-dimensional radiotherapy alone with concurrent chemoradiotherapy for non-surgical esophageal carcinoma.
Tan L; Xiao Z; Zhang H; Chen D; Feng Q; Zhou Z; Lv J; Liang J; Yin W
Cancer Radiother; 2020 Feb; 24(1):21-27. PubMed ID: 32001131
[TBL] [Abstract][Full Text] [Related]
16. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.
Zhao Q; Hu G; Xiao W; Chen Y; Shen M; Tang Q; Ning X
Medicine (Baltimore); 2017 Sep; 96(35):e7920. PubMed ID: 28858114
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Esophageal Squamous Cell Carcinoma Induction chemotherapy in Esophageal Squamous Cell Carcinoma.
Hosseini Toudeshki S; Garousi M; Arefpour AM; Fadavi P; Basi A; Foroughi A; Javadinia SA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1183-1188. PubMed ID: 38679976
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
Yang X; Wang L; Du H; Lin B; Yi J; Wen X; Geng L; Du X
Medicine (Baltimore); 2021 Jan; 100(3):e24328. PubMed ID: 33546064
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method.
Chen X; Zhu X; Liang Z; Li L; Qu S; Chen K; Pan X
Onco Targets Ther; 2017; 10():2909-2921. PubMed ID: 28652773
[TBL] [Abstract][Full Text] [Related]
20. Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A).
Wang L; Wang X; Ren X; Han C; Xiao Z; Zhu S; Qiao X; Zhou Z; Shen W; Chen J; Pang Q; Zhang W; Zhao Y; Wang X; Sun X; Ge X; Zhang K; Hu M; Li G; Liu M; Wang Y
Transl Cancer Res; 2021 Jun; 10(6):2932-2943. PubMed ID: 35116602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]